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Objectives: To identify the prevalence, risk factors, and outcomes 
of intra-abdominal hypertension in a mixed multicenter ICU pop-
ulation.
Design: Prospective observational study.
Setting: Fifteen ICUs worldwide.
Patients: Consecutive adult ICU patients with a bladder catheter.
Interventions: None.
Measurements and Main Results: Four hundred ninety-one 
patients were included. Intra-abdominal pressure was measured a 
minimum of every 8 hours. Subjects with a mean intra-abdominal 
pressure equal to or greater than 12 mm Hg were defined as hav-
ing intra-abdominal hypertension. Intra-abdominal hypertension 
was present in 34.0% of the patients on the day of ICU admission 
(159/467) and in 48.9% of the patients (240/491) during the 
observation period. The severity of intra-abdominal hypertension 
was as follows: grade I, 47.5%; grade II, 36.6%; grade III, 11.7%; 
and grade IV, 4.2%. The severity of intra-abdominal hypertension 
during the first 2 weeks of the ICU stay was identified as an inde-
pendent predictor of 28- and 90-day mortality, whereas the pres-
ence of intra-abdominal hypertension on the day of ICU admission 
did not predict mortality. Body mass index, Acute Physiology and 
Chronic Health Evaluation II score greater than or equal to 18, 
presence of abdominal distension, absence of bowel sounds, 
and positive end-expiratory pressure greater than or equal to 
7 cm H2O were independently associated with the development 
of intra-abdominal hypertension at any time during the observa-
tion period. In subjects without intra-abdominal hypertension on 
*See also p. 608.
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day 1, body mass index combined with daily positive fluid balance 
and positive end-expiratory pressure greater than or equal to 7 cm 
H2O (as documented on the day before intra-abdominal hyper-
tension occurred) were  associated with the development of intra-
abdominal hypertension during the first week in the ICU.
Conclusions: In our mixed ICU patient cohort, intra-abdominal hy-
pertension occurred in almost half of all subjects and was twice as 
prevalent in mechanically ventilated patients as in spontaneously 
breathing patients. Presence and severity of intra-abdominal hy-
pertension during the observation period significantly and inde-
pendently increased 28- and 90-day mortality. Five admission day 
variables were independently associated with the presence or de-
velopment of intra-abdominal hypertension. Positive fluid balance 
was associated with the development of intra-abdominal hyper-
tension after day 1. (Crit Care Med 2019; 47:535–542)
Key Words: intra-abdominal hypertension; intra-abdominal 
pressure; prevalence; risk factors 
Recent single-center studies have reported the pres-ence of intra-abdominal hypertension (IAH) (1, 2) in 38–45% of all adult patients treated in an ICU setting 
(3–5). Previously published multicenter studies have included 
only selected patients (with an expected ICU stay > 24 hr) and 
observed even higher proportions of patients with IAH (6, 7).
IAH may lead to organ dysfunction and abdominal compart-
ment syndrome (ACS) (1–11). However, research findings are 
conflicting as to whether IAH is independently associated with 
increased mortality (3–5, 7, 12, 13). Many risk factors have been 
associated with IAH, but the results have varied depending on 
the definitions used and the population studied (7, 10–16).
In summary, the actual prevalence, outcome, and risk fac-
tors of IAH are still unclear. To date, this is the first prospective 
multicenter observational study to include a large, consecu-
tively enrolled mixed ICU population.
The objectives of this study were: 1) to identify the occur-
rence of IAH and the IAH severity grades on the day of ICU 
admission and during the observed period of ICU stay, 2) 
to investigate whether IAH is independently associated with 
increased 90-day mortality, and 3) to identify the factors asso-
ciated with the development of IAH during an ICU stay.
MATERIALS AND METHODS
Patients and Measurements
The Ethics Committee of the South Metropolitan Health Service 
in Perth, Australia (13/20), approved the study with a waiver of 
informed consent, as the criteria set out by the Australian Na-
tional Health and Medical Research Council were fulfilled. Sub-
sequently, institutional ethics committees for each site approved 
the study. Only deidentified patient data were collected. The 
study was also approved and registered as an official Abdominal 
Compartment Society study (No 16, www.wsacs.org).
A detailed description of site selection, patient inclu-
sion criteria, intra-abdominal pressure (IAP) measurements, 
and data collection is presented in Supplemental Methods 
(Supplemental Digital Content 1, http://links.lww.com/CCM/
E253), and daily variables (documented each day until ICU 
discharge or 14 d) considered for regression analyses are pre-
sented in Supplemental Table 1 (Supplemental Digital Content 
2, http://links.lww.com/CCM/E254).
IAH and ACS were defined as previously described (2). The 
severity of IAH was graded as follows: grades I–IV were de-
fined as IAP 12–15, 16–20, 21–25, and greater than 25 mm Hg, 
respectively (2).
Mean IAP for each patient on each study day was calculated, 
and patients were categorized as having IAH if they had at least 
1 day with a mean IAP of 12 mm Hg or higher.
Maximum IAH grade was determined based on the highest 
mean IAP of any study day.
Primary IAH was defined as IAH in the setting of an injury 
or disease in the abdominopelvic region (2).
Sample Size Calculation and Statistical Analysis
Details on sample size calculation and statistical analysis are 
presented in Supplemental Methods (Supplemental Digital 
Content 1, http://links.lww.com/CCM/E253).
Missing data are reported in Supplemental Table 1 (Supplemental 
Digital Content 2, http://links.lww.com/CCM/E254).
The effect of different sites was estimated with the design 
effect formula (17) and controlled for by using stepwise regres-
sion analysis based on generalized estimating equations in all 
of our regression analyses.
RESULTS
This study included 491 patients from 15 sites (12 mixed, three 
surgical ICUs) (see flow diagram in Supplemental Figure 1 
(Supplemental Digital Content 3, http://links.lww.com/CCM/
E256; legend, Supplemental Digital Content 8, http://links.
lww.com/CCM/E260). Site descriptions are presented in Sup-
plemental Table 2 (Supplemental Digital Content 4, http://
links.lww.com/CCM/E255). The design effect for sites for IAH 
on any study day was 5.6 and that for 90-day mortality was 2.2.
In 24 patients (4.9%), IAP was not measured on the day 
of ICU admission but was measured on subsequent days. Of 
the 467 patients in whom IAP was measured on the admission 
day, 159 (34.0%) had IAH. An additional 81 of 491 (16.5%) 
developed IAH later during their ICU stay (up to 14 study 
days) (Fig. 1). From day 7 onward, only an additional seven of 
491 (1.4%) patients developed IAH. We therefore limited the 
observations between ICU days 2–7 to establish risk factors for 
the development of IAH during the ICU stay.
Altogether, 240 of 491 patients (48.9%) suffered from IAH 
during the observation period, nearly half of whom (46.3%) 
had Primary IAH. Although 114 of the IAH patients (47.5%) 
had IAP that remained between 12 and 15 mm Hg (IAH grade I) 
(Fig. 2), ACS was noted in 31 patients (6.3%) in total, and in 
19 patients (3.9%), ACS was present on the day of ICU admis-
sion. Decompressive laparotomy was performed in 13 patients 
(in one patient twice); open abdomen treatment was thereafter 
applied in 11 patients (10 with vacuum-assisted closure).
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Baseline characteristics according to the presence or ab-
sence of IAH are shown in Table 1. IAH was observed in 99 
medical patients (53.2%), in 86 emergency surgical patients 
(56.6%) and in 55 elective 
surgical patients (35.9%) 
(p = 0.002). There was no differ-
ence in IAH occurrence when 
comparing medical versus sur-
gical patients (Table 1).
In total, 6,838 IAP mea-
surements during 2,716 
patient-days were recorded. 
Daily mean IAPs in mechani-
cally ventilated and spontane-
ously breathing patients are 
presented in Supplemental 
Figure 2 (Supplemental 
Digital Content 5, http://
links.lww.com/CCM/E257; 
legend, Supplemental Digital 
Content 8, http://links.lww.
com/CCM/E260).
IAH and Outcome
Both 28- and 90-day mor-
tality were significantly higher 
in patients with IAH than in 
patients who never developed 
IAH (Table 1). The grade of 
IAH was inversely related to 
outcome (Fig. 2). The mortality 
of ACS was 67.7% at 28 days 
and 75.9% at 90 days. Of all 
nonsurvivors, 46.3% of patients 
without IAH, 43.8% of patients 
with IAH, and 68.4% of patients 
with ACS died during the first 7 
days of the observation period.
Stepwise regression analy-
ses revealed that both the pres-
ence of IAH during ICU stay 
and its maximum grade carry 
a significant risk of mortality. 
Presence of IAH on the day of 
ICU admission, regardless of 
grade, did not demonstrate any 
significance in mortality pre-
diction. The best models for 
90- (Table 2) and 28-day mor-
tality (Supplemental Table 3, 
Supplemental Digital Content 
6, http://links.lww.com/CCM/
E258) prediction included max-
imum IAH grade. However, 
IAH on any study day regard-
less of grade was also identi-
fied as an independent predictor of mortality. In the regression 
analysis model of 28-day mortality, the presence of IAH was less 
predictive than maximum IAH grade, whereas models with IAH 
Figure 1. Cumulative prevalence of intra-abdominal hypertension (IAH) and abdominal compartment syndrome 
(ACS). Data for ACS are presented as number of patients. Data for IAH are presented as number of patients 
(%) and include ACS patients. Proportion of patients with IAH from the total study cohort (491 patients) is 
presented.
Figure 2. Proportion of patients with different intra-abdominal hypertension (IAH) grades and respective 
mortality rates. Data for number of patients per IAH grade. Mortality presented in relation to maximum IAH 
grade at any time during the ICU stay.
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presence and maximum IAH grade performed similarly for the 
prediction of 90-day mortality. The best model for prediction 
of 28-day mortality included admission day lactate, fluid bal-
ance, presence of sepsis, neurologic and hematologic Sequential 
Organ Failure Assessment subscores, and maximum IAH grade 
during the ICU stay (Supplemental Table 3, Supplemental 
Digital Content 6, http://links.lww.com/CCM/E258).
Patients with IAH had longer ICU and hospital lengths of 
stay, as well as longer duration of mechanical ventilation, than 
patients without IAH (Table 1).
Risk Factors for Having IAH During the Observation 
Period
Thirty-eight of 64 admission day characteristics were signif-
icantly different between the patients with and without IAH. 
The risk factors that were considered for entry in the regression 
analysis can be found in Supplemental Table 1 (Supplemental 
Digital Content 2, http://links.lww.com/CCM/E254), together 
with details on missing data, and cutoff values separating non-
IAH versus IAH patients in our study cohort. The regression 
analysis identified admission day variables, including BMI greater 
than or equal to 27 kg/m2, Acute Physiology And Chronic Health 
Evaluation (APACHE) II greater than or equal to 18, presence 
of abdominal distension, absence of bowel sounds, and positive 
end-expiratory pressure (PEEP) greater than 7 cm H
2
O, as being 
independently associated with IAH (Table 3). Eleven patients 
(12.8%) developed IAH despite the absence of these factors.
Risk Factors for Patients Developing IAH During 
Their ICU Stay (Days 2–7)
Independent risk factors for the development of IAH be-
yond the ICU admission day included BMI, daily positive 
TABLE 1. Admission Day Variables and Outcome Data
Variables All No IAH
IAH
p No IAH   
vs IAH EverIAH Ever
IAH on Day  
of ICU  
Admission
IAH Occurred 
After Day1
n (%) 491 (100) 251 (51.1) 240 (48.9) 159 (32.4) 81 (16.5)  
Age, median (IQR) 61 (18–94) 62 (20–91) 61 (49–72) 59 (21–94) 62 (20–86) 0.960
Male gender, n (%) 276 (56.2) 131 (52.2) 145 (60.4) 96 (60.4) 49 (60.5) 0.066
Body mass index, kg/m2,  
median (IQR)
26 (23–31) 25 (23–29) 28 (24–32) 27 (25–32) 28 (24–32) < 0.001
Surgery, n (%) 305 (62.2) 164 (65.3) 141 (58.7) 102 (64.2) 42 (51.9) 0.133
Abdominal surgery, n (%) 126 (25.7) 95 (37.8) 89 (37.1) 68 (42.8)a 21 (25.9) 0.861
Mechanical ventilation, n (%) 317 (64.6) 140 (55.8) 177 (73.8) 112 (70.4) 65 (80.2) < 0.001
Vasopressors, n (%) 220 (44.8) 96 (38.2) 124 (51.7) 85 (53.5) 39 (48.1) 0.002
Acute Physiology And  
Chronic Health Evaluation  
II score, median (IQR)
16 (11–23) 15 (10–19) 19 (13–25) 19 (15–26) 20 (14–28) < 0.001
Fluid balance in the ICU, L,  
median (IQR)
2.7 (2.0–4.4) 2.5 (1.8–4.1) 3.1 (2.1–4.5) 3.1 (2.2–5.1) 3.3 (1.9–4.9) 0.001
Central venous pressure, mm Hg,  
median (IQR)
10 (7–15) 8.0 (5–12) 13 (9–17) 13 (8–11) 14 (11–18) < 0.001
Lactate, mmol/L, median (IQR) 2.0 (1.2–3.5) 1.8 (1.1–2.9) 2.4 (1.3–4.3) 2.6 (1.6–5.9) 2.2 (1.2–3.2) 0.001
Sequential Organ Failure  
Assessment score, median (IQR)
5.0 (3.0–9.0) 4.5 (2.0–7.0) 7 (4.0–10.0) 8.0 (5.0–11.0) 8.0 (5.0–9.0) < 0.001
28-d mortality, n (%) 92 (18.7) 27 (10.8) 65 (27.1) 45 (28.5) 20 (24.7) < 0.001
90-d mortality, n (%) 129 (26.3) 41 (16.3) 88 (36.7) 59 (38.6) 29 (36.3) < 0.001
Mechanical ventilation  
duration, d, median (IQR)
3 (1–8) 1 (1–5) 5 (1–10) 4 (1–10) 6 (3–13) < 0.001
ICU stay, d, median (IQR) 5 (2–12) 3 (2–8) 7 (3–13) 6 (3–13) 7 (4–15) < 0.001
Hospital stay, d, median (IQR) 17 (9–30) 15 (8–26) 18 (11–32) 18 (9–32) 19 (15–33) < 0.001
IAH = intra-abdominal hypertension, IQR = interquartile range.
a Significant difference in comparison of “IAH on day of ICU admission” vs “IAH occurred after day 1”.
Boldface values indicate comparisons with significant difference.
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fluid balance, and PEEP greater than 7 cm H
2
O (the latter two 
documented on the day before IAH occurred) (Supplemental 
Table 4, Supplemental Digital Content 7, http://links.lww.com/
CCM/E259).
DISCUSSION
The present study is the first multicenter prospective observa-
tion on prevalence, risk factors, and outcome of IAH among 
the consecutive patients admitted to the ICU. The results partly 
confirm the findings of previous studies but also add some im-
portant new insights to the field.
Prevalence of IAH
The prevalence of IAH during the first 24 hours of admission was 
34%, which is comparable with the result of a previously pub-
lished multicenter study (7). However, this study included only 
patients with an expected ICU stay greater than 24 hours (7). 
Consecutive patients admitted to the ICU were studied in 
several recent single-center studies (3–5). Only one of these 
studies reported the prevalence of IAH on the day of ICU ad-
mission and found a similar prevalence (30%) as our study (5).
The daily dynamics of IAP have been presented in some 
previous studies (7, 12), whereas cumulative prevalence (5, 12) 
and risk factors of IAH (4, 5, 15) have been described in detail 
in only single-center studies.
Similar to the most recent single-center report (5), our 
study revealed that in IAH patients, IAH was not present in 
one third of patients on their admission day but developed 
after day 1. In keeping with other studies, the occurrence of 
lower IAH grades is more common than the occurrence of 
higher grades of IAH (Fig. 2).
The cumulative prevalence of ACS in our study was rel-
atively high (6%), contradicting the recent suggestion by 
TABLE 2. Stepwise Regression Analysis for 90-Day Mortality Prediction
Variables OR 2.5% 97.5% p
n (%) of 
Patientsa
(Intercept) 0.031 0.015 0.064 < 0.0001  
Acute Physiology And Chronic  
Health Evaluation II
1.079 1.034 1.126 0.0005  
Maximum IAH grade I 1.098 0.583 2.067 0.7732 114 (23.2)
Maximum IAH grade II 2.251 1.200 4.223 0.0115 88 (17.9)
Maximum IAH grade III 4.436 1.444 13.634 0.0093 28 (5.7)
Maximum IAH grade IV 1.594 0.440 5.771 0.4775 10 (2.0)
Sepsis 3.759 2.223 6.357 < 0.0001 108 (22.0)
Neuro SOFA 1 2.409 1.071 5.420 0.0335 60 (12.2)
Neuro SOFA 2 0.977 0.357 2.672 0.9639 45 (9.2)
Neuro SOFA 3 3.923 1.833 8.396 0.0004 39 (7.9)
Neuro SOFA 4 3.317 1.623 6.781 0.0010 72 (14.7)
IAH = intra-abdominal hypertension, OR = odds ratio, SOFA = Sequential Organ Failure Assessment.
a Proportion of patients in this category from total cohort.
Quasi-likelihood information criterion: [1] 393.6315. Admission day variables are combined with maximum IAH grade during the ICU stay.
TABLE 3. Stepwise Regression Analysis for Associated Variables of Intra-Abdominal 
Hypertension
Admission Day Variables OR 2.5% 97.5% p
(Intercept) 0.276 0.181 0.420 < 0.0001
Body mass index ≥ 27 kg/m2 1.937 1.168 3.210 0.010
Acute Physiology And Chronic Health  
Evaluation II ≥ 18 points
2.768 1.807 4.240 < 0.0001
Abdominal distension 3.191 1.503 6.773 0.003
Absence of bowel sounds 1.731 1.013 2.957 0.045
Positive end-expiratory pressure ≥ 7 cm H2O 2.339 1.351 4.048 0.002
OR = odds ratio.
Quasi-likelihood information criterion: [1] 485.8979.
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Balogh et al (18) that ACS is a disappearing syndrome (18). 
However, a recent single-center study by Murphy et al (5) re-
ported ACS in 2.8% of study patients. The most likely ex-
planation for the cumulative prevalence of ACS in our study 
being twice that of the study by Murphy et al (5) is the case 
mix in our multicenter study that included some sites ex-
clusively admitting patients with the highest illness severity 
and a very high prevalence of IAH (Supplemental Table 2, 
Supplemental Digital Content 4, http://links.lww.com/CCM/
E255). Other sites admitted less sick patients with a signif-
icant proportion of patients being admitted after elective 
major surgery and presenting without acute organ failure. 
Such centers reported less IAH and a smaller proportion of 
ACS. The observed design effects reflect greater heterogeneity 
among the sites than expected and confirm that our case mix 
is clearly different from recent single-center studies including 
consecutive patients (3–5).
IAH and Outcome
IAH has been shown to be associated with adverse outcomes 
in several studies (5, 7, 12, 13), but some single-center studies 
have not confirmed this finding (3, 4). Severity/grade of IAH 
may explain the contradictory observations regarding mor-
tality related to IAH in the literature. The overall effect of IAH 
on outcome may be a function of IAH severity because higher 
IAH grade is associated with higher mortality and vice versa. 
Accordingly, a site admitting less severe patients and observ-
ing only a few cases of IAH above grades I and II is likely to 
miss changes in mortality independently related to IAH. Our 
current study supports the differential impact of IAH grades 
on mortality (Table 2 and Fig. 2; and Supplemental Table 3, 
Supplemental Digital Content 6, http://links.lww.com/CCM/
E258). Earlier observations (4, 5) have shown that IAH grade I 
(12–15 mm Hg) may not increase mortality. It is possible that 
IAH to some degree (grade I, and possibly in some cases also 
grade II) just mirrors the severity of the underlying disease and 
its treatments while not by itself having an additional delete-
rious physiologic effect or leading to worse outcomes com-
pared with higher grade IAH.
Interestingly, in our study, IAH grade IV was associated 
with lower mortality than grade III (Table 2 and Fig. 2). This 
finding is likely due to the small number of patients present-
ing with grade IV (n = 10) (Table 2; and Supplemental Table 3, 
Supplemental Digital Content 6, http://links.lww.com/CCM/
E258). Our study, however, invites the discussion to consider 
the possibility of grouping grades III and IV together.
The severity of IAH needs to be considered when carrying 
out future research and in providing future treatment recom-
mendations. More aggressive and invasive treatment strategies 
(e.g., deep sedation, hemofiltration to restore fluid balance) 
suggested by the Guidelines (2, 16) are probably justified only 
in patients with severe IAH (possibly grade II and above). 
However, the results of several experimental studies have 
shown a negative impact of IAH on organ blood flow occur-
ring with IAP values as low as 10–15 mm Hg (19–22), sup-
porting the pathophysiologic rationale for keeping the cutoff 
of IAH at 12 mm Hg. Several clinical studies have confirmed 
that an IAP of 12 mm Hg and above results in increased mor-
tality (6, 7, 10–12). In contrast, Petro et al (23) introduced the 
term “permissible IAH”, suggesting that presence of grades I–II 
IAH for a limited time period after elective surgery for ventral 
hernia repair does not negatively affect outcome. These con-
flicting results once again indicate the importance of further 
distinction between IAH severity grades instead of addressing 
IAH as a “yes-or-no” phenomenon. Furthermore, the absolute 
value of IAP alone is probably not an effective trigger for dis-
tinct therapeutic measures. It is important to consider the dy-
namics of IAP with the underlying disease when treating any 
patient or in the development of management recommenda-
tions (2, 16).
Risk Factors
Our study is the first prospective multicenter study investigat-
ing consecutive adult patients worldwide. This study provides 
detailed insight into the risk of IAH at admission to the ICU 
and the changing risks that arise during a patient’s ICU stay. 
Similar to previous reports, BMI and disease severity (3–5, 15) 
were associated with IAH. Mechanical ventilation has been 
an inclusion criterion in several studies addressing IAH in 
the ICU (12, 15), but the most recent single-center study also 
identified mechanical ventilation as a risk factor for IAH (5). In 
our current study, mechanical ventilation as a yes/no variable, 
compared with categorization by PEEP greater than or equal 
to 7 cm H
2
O, had less power in identifying the presence of IAH 
on the day of ICU admission or the development of IAH dur-
ing the ICU stay. Additionally, independent associations were 
found with only subjectively assessable variables, such as ab-
dominal distension and absent bowel sounds. In several cases, 
causality remains unclear and may differ case-by-case (e.g., 
does PEEP increases IAP or IAH necessitates higher PEEP, or 
are absent bowel sounds a sign of ileus leading to IAH or does 
IAH disturb bowel peristalsis?). BMI is, in this case, the only 
variable with a clearly unidirectional effect, although its role in 
determining outcome is not clear. Higher baseline IAP, as seen 
in obese patients, is possibly not a cause of adverse outcomes. 
In our analysis, BMI was the only identified risk factor that 
was not directly related to increased mortality in the univariate 
analysis. At this time, it is not clear whether different cutoffs for 
IAH should be used in obese patients.
An important finding of our study is that positive fluid bal-
ance, shown to be a risk factor for IAH in several studies (4, 
5, 14), may be most relevant later in the ICU stay, following 
aggressive resuscitation, when resistance to fluid mobilization 
is present.
Strengths and Limitations
The main strength of this study is the multicentered contri-
bution of ICUs from around the world enrolling consecutive 
patients and performing IAP measurements throughout the 
ICU stay. This multicenter worldwide design has strength in 
that it is more likely to capture a large range of current prac-
tices but, at the same time, has the potential weakness of not 
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being reproducible for individual centers. Our study was not 
powered to perform a meaningful post hoc subgroup analysis 
for different continents or patient severity groups. We did not 
assess limitations of care (e.g., do not resuscitate orders) that 
were applied during the study period, possibly affecting our 
results regarding the effect of IAH on mortality (24). Other 
limitations, also related to the multicenter and investigator-
initiated design of the study, include a long period for site re-
cruitment and relevant differences between the sites. These 
differences are reported in the article and their effect controlled 
by using a regression method that allowed for clustering. Other 
important strengths of the study include novel information re-
garding the development of IAH in critically ill patients after 
the day of ICU admission and outcome data beyond the ICU 
period (90-d mortality).
CONCLUSIONS
In our mixed ICU patient cohort, we found that almost half 
of all patients admitted to the ICUs worldwide developed 
IAH and that two thirds of those cases were already present 
on the day of ICU admission. Our data further demonstrated 
that IAH occurred twice as often in mechanically ventilated 
patients as in spontaneously breathing patients. Most impor-
tantly, the presence and severity of IAH during the first 2 weeks 
of the ICU stay significantly and independently increased 28- 
and 90-day mortality, whereas the presence of IAH on the day 
of ICU admission was insufficient to predict these adverse 
outcomes.
The admission day variables independently associated with 
the presence or development of IAH included BMI greater 
than or equal to 27 kg/m2, APACHE II greater than or equal to 
18, PEEP greater than 7 cm H
2
O, presence of abdominal dis-
tension, and absence of bowel sounds. Positive fluid balance, 
in addition to BMI and PEEP, was associated with the develop-
ment of IAH beyond the day of ICU admission.
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